Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Antispike is an anti-adhesion barrier gel developed for the prevention of postoperative abdominal adhesions. It is designed for single-use intraperitoneal administration during surgical procedures, such as for acute phlegmonous appendicitis, to provide a temporary physical separation between internal tissues and organs during the critical stages of the healing process. By acting as a mechanical barrier, the gel prevents the formation of fibrin bridges and subsequent fibrous adhesions between traumatized tissues. The product is developed and manufactured by the Belarusian Republican Unitary Enterprise Unitekhprom BSU.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Antispike.